Compound Summary
62717-42-4
Compound Information
62717-42-4
Compound Name: | 62717-42-4 |
Compound CID: | 147514 |
Synonyms: | 62717-42-4 SKF 38393 hydrochloride SKF38393 HCl SKF-38393 hydrochloride SKF 38393 (hydrochloride) More... |
Iupac Name: | 5-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepine-7,8-diol;hydrochloride |
InChI: | InChI=1S/C16H17NO2.ClH/c18-15-8-12-6-7-17-10-14(13(12)9-16(15)19)11-4-2-1-3-5-11;/h1-5,8-9,14,17-19H,6-7,10H2;1H |
InChIKey: | YEWHJCLOUYPAOH-UHFFFAOYSA-N |
Canonical Smiles: | C1CNCC(C2=CC(=C(C=C21)O)O)C3=CC=CC=C3.Cl |
Isomeric Smiles: | C1CNCC(C2=CC(=C(C=C21)O)O)C3=CC=CC=C3.Cl |
Molecular Weight: | 291.77 |
Molecular Formula: | C16H18ClNO2 |
Compound Structure
2D Structure:
3D Structure:
Computed Properties
62717-42-4
Molecular Weight: | 291.77 |
Molecular Formula: | C16H18ClNO2 |
Hydrogen Bond Donor Count: | 4 |
Hydrogen Bond Acceptor Count: | 3 |
Rotatable Bond Count: | 1 |
Heavy Atom Count: | 20 |
Complexity: | 291 |
Synonyms
62717-42-4
| 62717-42-4 | 62717-42-4 |
|---|---|
62717-42-4 |
SKF 38393 hydrochloride |
SKF38393 HCl |
SKF-38393 hydrochloride |
SKF 38393 (hydrochloride) |
SKF-38393 HCl |
1-Phenyl-2,3,4,5-tetrahydro-1H-benzodazepine-7,8-diol hydrochloride |
(+/-)-SKF-38393 hydrochloride |
SKF-38393A |
1H-3-Benzazepine-7,8-diol, 2,3,4,5-tetrahydro-1-phenyl-, hydrochloride |
2-phenyl-4-azabicyclo5.4.0undeca-7,9,11-triene-9,10-diol |
(R)-SKF 38393 (hydrochloride) |
62717-42-4 (HCl) |
C16H17NO2.HCl |
(+/-)-SKF-38393 hydrochloride;SKF-38393A |
81633-77-4 |
CHEMBL542700 |
(+/-)-1-Phenyl-2,3,4,5-tetrahydro-(1H)-3-benzazepine-7,8-diol hydrochloride |
SR-01000075378 |
SKF 38393A |
MLS000859931 |
SKF 38393 HCl |
SCHEMBL3425787 |
(y)-SKF-38393 hydrochloride |
AOB5359 |
DTXSID20936175 |
(?)-SKF-38393 hydrochloride |
BCP28880 |
EX-A3563 |
Tox21_500436 |
1-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepine-7,8-diol hydrochloride |
2,3,4,5-Tetrahydro-1-phenyl-1H-3-benzazepine-7,8-diol hydrochloride |
HY-12520A |
MFCD00069248 |
NSC320959 |
AKOS016012197 |
CCG-221740 |
CS-5354 |
LP00436 |
NSC 320959 |
NSC-320959 |
NCGC00093856-01 |
NCGC00261121-01 |
AC-32754 |
AS-16874 |
SMR000326792 |
D-047 |
EU-0100436 |
S7993 |
(+/-)-SKF-38393 Hydrochloride, Crystalline |
C75947 |
( inverted question mark)-SKF-38393 hydrochloride |
SR-01000075378-1 |
( inverted exclamation markA)-SKF38393 hydrochloride |
( inverted exclamation markA)-SKF-38393 hydrochloride |
(+/-)-SKF-38393 hydrochloride, crystalline, >=98% (HPLC) |
(+/-)-1-Phenyl-2,3,4-tetrahydro(1H)-3-benzapezine-7,8-diol HCl |
5-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepine-7,8-diol;hydrochloride |
(+/-)-1-Phenyl-2,3,4-tetrahydro(1H)-3-benzapezine-7,8-diol hydrochloride |
( inverted question mark)-1-Phenyl-2,3,4,5-tetrahydro-(1H)-3-benzazepine-7,8-diol hydrochloride |
Experimental Data
62717-42-4
| Species | Dose | Unit | Control(Avg days) | Treatment(Avg days) | Avg/Med Lifespan Change(%) | Control(Max days) | Treatment(Max days) | Max Lifespan Change(%) | Significant | Strain | Gender | PubMed | Avg/Med Lifespan Change tab |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Caenorhabditis elegans | 33.000000000000000 | umol/L | 5.000000000000000 | NS | N2 | 24134630 | Inactive |
Experimental Data Visualization
62717-42-4
Statistics Data
62717-42-4
| Species | Avg/Med Lifespan Change(%) | Max Lifespan Change(%) | Count Reference | Count Data point |
|---|---|---|---|---|
| Caenorhabditis elegans | 5.000000000000000 | 1 | 1 |
Statistics Data Visualization
62717-42-4
